chrisvoncsefalvay/vaers-outcomes huggingface dataset:
very bad reaction; felt like Covid all over again; headache; fever; was in bed for days, more tired than normal; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (very bad reaction), PYREXIA (fever), HEADACHE (headache), MALAISE (felt like Covid all over again) and FATIGUE (was in bed for days, more tired than normal) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2020. Concomitant products included OMEPRAZOLE and PAROXETINE for an unknown indication, HMG COA REDUCTASE INHIBITORS.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced HYPERSENSITIVITY (very bad reaction), PYREXIA (fever), HEADACHE (headache), MALAISE (felt like Covid all over again) and FATIGUE (was in bed for days, more tired than normal). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (very bad reaction), PYREXIA (fever), HEADACHE (headache), MALAISE (felt like Covid all over again) and FATIGUE (was in bed for days, more tired than normal) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other medications also include vitamins and something for stomach.
raised, red, sore patch at injection site 1x2 inches chicken pox rash 11/11/2009 swollen, stinging eyelid
Patient has facial swelling, states it happened the morning after her vaccine. Since the shot (11/1), she has not seen much improvement (on 11/4). Patient says swelling is acompanied with itching. Has use some type of cream to help with itching, has done nothing for swelling.  Patient gets flu shot every year and this was first time she had a reaction. No allergies
? PATIENT CALLED PHARMACY AT 10:55 AM ON 2/22/2020 and stated, "she wanted to know if she should be concerned about the reaction she is having to her Shingles vaccine administered on 02/18/2020" ? She reported classic signs of an injection site reaction: localized itching, redness, sore arm, skin felt feverish/warm to the touch. only at the site of the injections. ? I informed patient that reactions is common for this vaccination, and gave her information on how to care for the reactions and possibles signs of concern when she might need to escalate care. ? Event: Injection-site reaction ? Symptoms: Soreness of injection site, Inflammation, Itching/Swelling ? Pharmacist Response: Apply a cold compress to the site for approximately 15 minutes if the patient has any inflammation/swelling/or soreness. Recommend an analgesic such as acetaminophen or non-steroid anti-inflammatory drug. An anti-histamine can be used for any swelling make sure to observe and discuss with the patient signs of generalized anaphylaxis. ? Informed patient we would follow up on Monday to check on the status of the reaction. Cont... 02/23/2020 - Patient came to pharmacy to show me the reactions. - The reaction was consistent with anaphylaxis "serious allergy" - The patient presented with generalized itching and erythema to the full upper right portion of the left arm. - No signs of Hives, shortness of breath, or cardiovascular issues were present. - Patient stated she would see treatment with an Urgent Care Provider. Event Details
Approximately 3 hrs post receiving vaccine, she took a nap-woke up and couldn't move. States she felt nausea then it wore off. Got up and vomited. Better now at 2:20 approximately 2 hrs after incident. Inst. to see physician today.
This spontaneous report has been received from a Nurse, concerning a 66 year old patient of unknown gender. The patient's medical history, concurrent condition and concomitant medication were not provided. On an unknown date in 2016 (reported as "last year", the patient was vaccinated with a dose of PREVNAR 13 (dose, strength, route of administration were not provided) for prophylaxis. Then approximately in April 2017 (reported as within the last month), the patient was vaccinated with a dose of PNEUMOVAX23, intramuscular, lot # reported as N0039997 and expiration date of 20-OCT-2018 (dose and frequency were not provided) for prophylaxis. In April 2017, the patient experienced blood red areas around the arm (erythema), swollen, warm to touch, nothing at the injection site. The patient was treated with MEDROL dose pack and ATARAX as also experienced itching. It was unknown by the reporter if laboratories studies were performed. The patient was recovering from these events on an unknown date in April 2017. However, in April 2017, the patient died. It was unknown whether an autopsy was performed. The patient's cause of death was not provided. The causal relationship between the therapy with PNEUMOVAX23 and the events of blood red areas around the arm, swollen, warm to touch, itching and death was not reported. Upon internal review the patient's death was considered medically significant. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA004706: US-009507513-1704USA013548.
Patient received Moderna bivalent vaccine as the first dose of primary series. Per patient, the primary Moderna vaccine was requested, but the request was not communicated clearly and explicitly to pharmacy staff.
Rash appeared a couple of weeks after the Moderna Vaccine and has become considerably worse after ingesting eggs yesterday. Rash appeared swollen, red, purulent on both hands. Encouraged her to visit her MD
Itchy on deferents parts of body, when scratched the skin a dermographism is notated and also with rash.  This last minutes and then disappear.
I still have a small rash on my back; still in pain.; still unable to sit; sleep comfortable; Not able to do anything; nerve damage/nerve pain in left arm  and armpit; Nerve pain; nerve damage/nerve pain in left arm  and armpit; nerve damage/nerve pain in left arm  and armpit; This case was reported by a consumer via call center representative and described the occurrence of nerve damage in a 73-year-old patient who received Herpes zoster (Shingrix) (batch number YM74C, expiry date 8th March 2022) for prophylaxis.   On 22nd July 2020, the patient received Shingrix. On 22nd July 2020, less than a day after receiving Shingrix, the patient experienced nerve damage, nerve pain, axillary pain and pain in arm. On an unknown date, the patient experienced rash, pain, mobility decreased, sleep disorder and activities of daily living impaired. On an unknown date, the outcome of the nerve damage, nerve pain, pain and sleep disorder were not recovered/not resolved and the outcome of the axillary pain, pain in arm, rash, mobility decreased and activities of daily living impaired were unknown.   The reporter considered the nerve damage, nerve pain, axillary pain, pain in arm, rash, pain, mobility decreased, sleep disorder and activities of daily living impaired to be related to Shingrix.  Additional information was provided as follows: The patient received Shingrix and had terrible reactions which included nerve damage and pain in left arm and armpit. The patient also developed rash on her back and nerve pain. The patient visited emergency room for this and was on IV, The patient was unable to sit or sleep comfortably. The patient had a small business and was not able to help husband due to this. The reporter consented for follow up.
Sore arm; Tired; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and CHILLS (Chills) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm), FATIGUE (Tired) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. Treatment information was not reported.
Pfizer BioNTech and Janssen (J&J) COVID Vaccines: COVID-19 case resulting in Hospitalization / Death. Rec'd Pfizer BioNTech on 1/14/21 and 2/3/21 and Janssen (J&J) on 1/13/22. Presented to the ED for hypoxia. Admitted for acute hypoxemic resp failure 2/2 Covid19. Rec'd dexamethasone, azithromycin, and ceftriaxone. Patient progressively worsened and was transitioned to comfort care. Patient expired 6/28/22.
Felt very sick; Very weak; Coughs all the time; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Felt very sick), ASTHENIA (Very weak) and COUGH (Coughs all the time) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020. Concurrent medical conditions included Cholesterol and Blood pressure high.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Felt very sick), ASTHENIA (Very weak) and COUGH (Coughs all the time). At the time of the report, VACCINATION COMPLICATION (Felt very sick), ASTHENIA (Very weak) and COUGH (Coughs all the time) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Severe Painless petechial hemorrhage w/o vision impairment, lasted for almost 2 weeks, spontaeouly cleared.  No history prior similar event, no drama, etc.  I do not wear contacts, etc.
localized reaction/induration initially ten minutes after vaccine administration.  vaccination at 2023 first symptom at 2033. Benadryl 25mg given half at 2033 and the remainder at 2036. pt c/o tingling tongue at this time. no difficulty breathing or visible swelling. VSS. new complaint of dry throat and given water at 2038. by 2045 pt reporting improvement in symptoms. 2053 VSS and no complaints from pt. induration/localized reaction decreased substantially and symptoms relieved. pt disposition home with family.
I23.6 MURAL THROMBUS OF HEART POST ACUTE MI 5/9/2023 HYPERNATREMIA
Info has been received from a physician concerning an unspecified pt who was vaccinated with a dose of MMRII. The pt was admitted to the hospital after vaccination (details of event not further specified). Through follow-up contact with a nurse, it was learned that the info concerning this pt was obtained per a hospital. She had no other info available to her.
lymph nodes are not as badly swollen but she thinks this is due to taking prednisone; throat is closed a little but not completely; sensation spread to her hands; sensation spread to her hands; restrictive breathing; enlarged lymph nodes; tingling and numbness in her feet.; tingling and numbness in her feet; "usual symptoms" such as chills and fever which lasted that day; "usual symptoms" such as chills and fever which lasted that day; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS ("usual symptoms" such as chills and fever which lasted that day), PYREXIA ("usual symptoms" such as chills and fever which lasted that day), PARAESTHESIA (tingling and numbness in her feet.), HYPOAESTHESIA (tingling and numbness in her feet) and PARAESTHESIA (sensation spread to her hands) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Autoimmune disorder.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced CHILLS ("usual symptoms" such as chills and fever which lasted that day) and PYREXIA ("usual symptoms" such as chills and fever which lasted that day). On 24-Mar-2021, the patient experienced PARAESTHESIA (tingling and numbness in her feet.) and HYPOAESTHESIA (tingling and numbness in her feet). On 07-Apr-2021, the patient experienced PARAESTHESIA (sensation spread to her hands), HYPOAESTHESIA (sensation spread to her hands), DYSPNOEA (restrictive breathing) and LYMPHADENOPATHY (enlarged lymph nodes). On 03-May-2021, the patient experienced LYMPHADENOPATHY (lymph nodes are not as badly swollen but she thinks this is due to taking prednisone) and THROAT TIGHTNESS (throat is closed a little but not completely). On 24-Feb-2021, CHILLS ("usual symptoms" such as chills and fever which lasted that day) and PYREXIA ("usual symptoms" such as chills and fever which lasted that day) had resolved. At the time of the report, PARAESTHESIA (tingling and numbness in her feet.), HYPOAESTHESIA (tingling and numbness in her feet), PARAESTHESIA (sensation spread to her hands), HYPOAESTHESIA (sensation spread to her hands), DYSPNOEA (restrictive breathing), LYMPHADENOPATHY (enlarged lymph nodes), LYMPHADENOPATHY (lymph nodes are not as badly swollen but she thinks this is due to taking prednisone) and THROAT TIGHTNESS (throat is closed a little but not completely) outcome was unknown. Not Provided          No concomitant details were provided.  Treatment details include Prednisone.  Action taken with mRNA-1273 in response to the events was not applicable.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 12 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Jul2021 18:45 (Lot number: FA7484) at the age of 12 years as dose 1, single for Covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: TDAP, administration date 12Jul2021. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 21Aug2021 20:00, outcome "recovering", described as "1st dose sore left arm and sore right arm per patient"; MYALGIA (non-serious) with onset 21Aug2021 20:00, outcome "recovering", described as "muscle aches". Therapeutic measures were not taken as a result of pain in extremity, myalgia. Additional information: Other medications in two weeks was None. No Covid prior vaccination. No Covid tested post vaccination. No Known allergies. No follow-up attempts are possible. No further information is expected.
Patient developed back and radiating right leg pain after 2nd vaccine administration.  Pain has persisted.    MRI shows lumbar stenosis and herniated disc.  Disc does not appear acute.  Patient relates that he has had a remote history of right leg pain in the past.  Patient has had epidural steroid injections.  He still has right leg numbness, dorsiflexion and ankle weakness.
Tingling tongue; Numb lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (Tingling tongue) and HYPOAESTHESIA ORAL (Numb lips) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PARAESTHESIA ORAL (Tingling tongue) and HYPOAESTHESIA ORAL (Numb lips). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 25-Feb-2021, PARAESTHESIA ORAL (Tingling tongue) and HYPOAESTHESIA ORAL (Numb lips) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
I have numbness & serve aches and pain  in my left arm, numbness down to my left hand chest muscles and shoulder pain
shingles NEAR the eye/Shingles (left side of face); blisters on face.; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 73-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In January 2023, the patient received the 1st dose of Shingrix. In January 2023, 2 days after receiving Shingrix, the patient experienced shingles and blister. The patient was treated with valaciclovir hydrochloride (Valtrex) and ophthalmologicals (nos) (Eye Drops (Ingredients Unknown)). On an unknown date, the outcome of the shingles and blister were not recovered/not resolved.   It was unknown if the reporter considered the shingles and blister to be related to Shingrix.   Additional Information: GSK Receipt Date: 20-FEB-2023 Reporter's Comment: The reporter was the patient. The reporter called stating that he was unsure if he ever had chicken pox.  The reporter was instructed by his primary care physician to have Shingrix administered, although he did not want to have the vaccine, he complied with the request of his primary care physician. Shingrix was administered approximately one month prior to his call to GlaxoSmithKline on a Wednesday.  Then two days later, on a Friday, the blisters appeared on the left side of his face.  The patient did not have shingles prior to the vaccination. He had blisters on the left side of his face. The reporter did not consent to follow-up. The reporter declined to provide any more information pertaining to his demographics or anything else related to this case. The minimal information obtained to file adverse event.
After 1st shot within 1 week developed DVT in left leg that was misdiagnosed and treated as a skin infection. After second shot ended up in ICU to have DVT in left leg confirmed and embolisms in both lungs. 1st week in March 2021, less than a week after second shot. May 27th back in hospital with multiple strokes, clots in all lobes, a brain hemorrhage and enlarged heart. Clots were showering to brain. Blood clots w/ low platelets (53,000). Released on eliquis after 1 week. July 1st admitted back into hospital with new stroke, hemorrhage is bigger. Clots, low platelets (40,000), gall stones, enlarged heart, fatty liver. Platelet transfusion, IVIG, steroid IV, Coumadin for life! Now being told possibly have autoimmune disorder called APS, not confirmed but never had any issues prior to COVID-19 vaccine.  Lost function in right hand. Now have aphasia and going to rehab facility. Being told will be on Coumadin rest of life due to blood clots and low platelets.
Severe muscle pain, moderate joint pain, chills, nausea, sore dry throat, numbness. Tylenol
Patient has a phobia of getting any kind of shots.. he passed out but still had a pulse.. we woke him up by yelling his name and his eyes fluttered and he was then able to talk and wanted water.. EMT came but patient denied services
Systemic: blood clots-Medium, Systemic: Nausea-Medium, Systemic: Neurological Disorder (diagnosed by MD)-Medium, Systemic: Stroke-Severe
DIED; SICK; This spontaneous report received from a consumer concerned multiple patients of an unspecified race and ethnicity. The patient's weight, height, and medical history were not reported. The patients received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin was not reported, batch number: unknown and expiry: unknown) dose 1, 1 total, dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. The consumer stated that there was 60 sick and 9 died out of millions from the vaccination on an unspecified date. On an unspecified date, the patients died from unknown cause of death. It was unspecified if an autopsy was performed.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patients died on an unspecified date, and the outcome of sick was not reported. This report was serious (Death).; Sender's Comments: V0- 20220743653 -covid-19 vaccine ad26.cov2.s- Died. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Pt vaccinated with MMR developed arthritic like symptoms. Swelling & pain in knee joints. 2nd day there was some improvement.
pt recv vax 25MAR96 & w/in 24hr of vax pt exp fever, chills, nausea & weakness;
high heart rate; fever; chills; weak; Initial information was received on 07-Aug-2020 regarding an unsolicited valid non-serious case received from a non-health care professional.  This case involves a 70 year old male patient who experienced fever (pyrexia), high heart rate (heart rate increased), chills and was weak (asthenia), while he received vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  The patient in the past was vaccinated with a dose of regular quadrivalent influenza vaccine on an unknown date, a dose of  Fluzone HD (high dose) on 26-OCT-2017 for prophylactic vaccination and  visited emergency room on 09-Nov-2017 also a dose of Fluzone HD on 09-OCT-2018 for prophylactic vaccination and visited emergency room on 14-Oct-2018 with events of fever, chills, weakness and high hear rate.  The patient's past medical treatment, concomitant therapy and family history were not provided.   On 18-Sep-2019, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient developed non-serious fever (pyrexia), high heart rate (heart rate increased), chills and was weak (asthenia), (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  The patient was visited to emergency room on 24-Sep-2019.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  On an unknown date, the patient had recovered from the events.  There will be no information available on the batch number for this case.
Erythema, slight edema onset 2 days after flu vaccine, one area that looks like a hive, central area measures 70x125mm.  "Hive" area 10mm.  LTDT.
Patient was administered a Pfizer Covid-19 vaccine that was exposed to a temperature excursion. (Vaccine was between 8-14.5 degrees C for 7hrs and 48 minutes). Pfizer was contacted and advised the clinic to consider the dose as invalid and to revaccinate. Patient was revaccinated on 03/19/21 and since has received dose 2 on 04/09/21.
I received the Influenza vaccine but am not sure of the exact name to pick from in the menu for item 17. As I started to remove my left arm from my shirt sleeve in preparation for the vaccine on Tuesday, 11/16/21, the person administering the vaccine stopped me and told me to pull down my shirt collar instead.  Almost immediately after the injection, I began experiencing extreme pain in my left arm.  As I was walking out of the room after the injection, I felt a strong pain and stinging and burning sensation.  It got worse overnight that day and worsened every day since for most of the following week.  I have been icing my arm and alternating between Ibuprofen and Acetaminophen, but it has not been getting any better. The pain also began extending into my left elbow and into my left hand. On Friday, 11/19/21, the pain began extending down my left side and into my left breast.  I felt a hard lump at the vaccination site, and it is swollen, warm, and red.